T 1324/21 (Rifaximin/SANDOZ) of 12.01.2024
- European Case Law Identifier
- ECLI:EP:BA:2024:T132421.20240112
- Date of decision
- 12 January 2024
- Case number
- T 1324/21
- Petition for review of
- -
- Application number
- 17712970.7
- IPC class
- A61K 31/437A61K 9/20A61K 9/28
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PHARMACEUTICAL COMPOSITION CONTAINING RIFAXIMIN ALPHA&DELTA
- Applicant name
- Sandoz AG
- Opponent name
- Alfred E. Tiefenbacher (GmbH & Co. KG)
Alfasigma S.P.A. - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54(2)European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 012(4)Rules of procedure of the Boards of Appeal 2020 Art 012(6)
- Keywords
- Late-filed facts - error in use of discretion at first instance (yes)
Amendment to case - suitability of amendment to address issues
Novelty - availability to the public
Inventive step - suitable starting point in the prior art - Catchword
- -
- Cited cases
- G 0001/92
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside
2. The patent is revoked